Vasilis Vasiliou designated the Bliss Professor of Epidemiology
Vasilis Vasiliou, newly designated as the Susan Dwight Bliss Professor of Epidemiology, focuses his research on investigating the mechanisms of cellular responses to environmental stress and gene-environment interactions involved in a number of diseases, including alcohol-induced liver disease and various forms of cancer such as colon and pancreatic cancer, gout, obesity and diabetes.
SU2C Names Yale Cancer Center's Dr. Charles Fuchs, Co-Leader of Dream Team on Colorectal Cancer
Stand Up To Cancer (SU2C) announced the formation of a “Dream Team” of top researchers to take on one of the toughest challenges in cancer research and treatment: colorectal cancer, which is expected to claim the lives of more than 50,000 Americans this year.
‘Explosive growth’ of interventional oncology prompts formation of new society
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established a society to further its mission. The Society of Interventional Oncology will be the only membership-based organization dedicated entirely to interventional oncology, a subspecialty field of interventional radiology. Jeff Geschwind Interventional oncology focuses on the treatment of cancer through minimally invasive procedures performed under image guidance, such as X-ray, MRI, PET scan, CT scan or ultrasound.
Local physician appointed to Commission on Cancer position
Preston Sprenkle , MD received a three-year appointment as Cancer Liaison Physician for the cancer program at VA Connecticut Healthcare System . Cancer Liaison Physicians are an integral part of cancer programs accredited by the American College of Surgeons Commission on Cancer (CoC).
Charles S. Fuchs to lead Yale Cancer Center and Smilow Cancer Hospital
After an extensive national search, Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center (YCC) have announced that Charles S. Fuchs, MD, MPH, will become the new YCC director and physician-in-chief at Smilow Cancer Hospital at Yale New Haven, effective Jan. 1, 2017.